The Great, The Not So Good As well as Everolimus

?1) but expressed no preference if the CHADS2 score was 2 or above when oral anticoagulation of any form was ��recommended,�� or where only additional risk factors (such as age 65�C74 years, female gender, and vascular disease) were present when oral anticoagulation was to be ��considered.��[29] A significant proportion of recommendations within a guideline are supported by level of evidence C: applied when a consensus of opinion has to be reached by the guideline committee because there is insufficient clear-cut evidence from clinical trials.[3, 5] As such, these recommendations illustrate what is considered ��best practice�� within the region covered by the guideline. Such recommendations are likely to differ between regions, and, hence, result in different recommendations in different geographies or cultures. An example of this from recent ESC AF guidelines is the restriction of the class I recommendation for echocardiographic http://www.selleckchem.com/products/ch5424802.html assessment to a subset of patients, whereas a class IIa recommendation is given for all-comers.[5] In comparison, the Canadians issue a strong recommendation based on low-quality evidence for routine echocardiography,[47] and the U.S. guidelines state unequivocally that a 2-D echocardiogram should be undertaken by all patients (not a recommendation but a ��given�� in the text).[3, 4, 6] The Canadian CVS opted to contraindicate dronedarone on the basis of reduced LV function derived from the echocardiogram, and abandoned the NYHA heart failure clinical classification, initially in those with an LV ejection http://www.selleckchem.com/products/azd9291.html fraction http://www.selleck.cn/products/Everolimus(RAD001).html assumes ready availability of echocardiography, and strong guidance to use it in all AF patients (see above). Regrettably, this guideline ignores patients with preserved ejection fraction heart failure, many of whom were included in the ATHENA trial,[48] and who may be just as great a risk as those with depressed LV function. In any event, the European guidelines could not entirely rely on echocardiographic findings since many patients with AF do not receive an echocardiogram. The resource availability within the guideline jurisdiction is also something that must concern guideline authors. Recommendations in guidelines, which cover regions with widely different socioeconomic conditions, must be applicable and useable by those in the most limited conditions. Guidelines issued by the ESC face this problem, having to provide workable guidance to a range of economies.[49] To contend with this issue, guideline committees have three major options: (1) provide a range of options from which a practitioner can select the appropriate intervention for his or her socioeconomic situation; (2) place the expensive recommendation as a lower class, allowing less well-off health services to ��opt out��; and (3) separately outline a minimum alongside an optimum level of care.